Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Change in Inventory: 2022-2024

Historic Change in Inventory for Zevra Therapeutics (ZVRA) over the last 3 years, with Dec 2024 value amounting to $8.9 million.

  • Zevra Therapeutics' Change in Inventory fell 66.72% to $194,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 32.63%. This contributed to the annual value of $8.9 million for FY2024, which is 4407.77% up from last year.
  • Latest data reveals that Zevra Therapeutics reported Change in Inventory of $8.9 million as of FY2024, which was up 4,407.77% from -$206,000 recorded in FY2023.
  • In the past 5 years, Zevra Therapeutics' Change in Inventory ranged from a high of $8.9 million in FY2024 and a low of -$206,000 during FY2023.
  • In the last 3 years, Zevra Therapeutics' Change in Inventory had a median value of -$147,000 in 2022 and averaged $2.8 million.
  • Per our database at Business Quant, Zevra Therapeutics' Change in Inventory plummeted by 40.14% in 2023 and then skyrocketed by 4,407.77% in 2024.
  • Yearly analysis of 3 years shows Zevra Therapeutics' Change in Inventory stood at -$147,000 in 2022, then plummeted by 40.14% to -$206,000 in 2023, then surged by 4,407.77% to $8.9 million in 2024.